Vascular Biogenics Ltd (VBLT)

[davidal66]

Even though I'm out, I still am highly interested in how this plays out... so I hope you guys don't mind me occasionally posting.

Positive upside prior to the interim . In the KOL event on NASH, Dror mentioned in the q and a that they are in discussions with a pharma regarding NASH. An upside prior to the interim could be a NASH partnership. Why now? If Dror is unsure of VB111 in rGBM, he may be pushing hard for a NASH partnership. The early phase II data was intriguing with VB201 and they have a backup which is more potent. Such a move would give them the cash to develop VB600 series compounds. Such a deal would really de-risk the entire interim analysis event. VB600 looks very good, it's very interesting, but early.

I did not bet on such an event, but it is a real possibility. From Dror's position, it makes sense. I would not be shocked by a NASH partnership or option to a partnership in the next few months.